semaglutide newtown square Treatment in Square, PA Weight Loss Injections - HD
Description
SHANGHAI, March 6 () - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said on WeChat on Friday, boosting competition in a market analysts expect to be worth billions in coming years.The injection belongs to the class of GLP-1 receptor agonist drugs sold locally by drugmakers such as Novo Nordisk, Eli Lilly, and Innovent Biologics.
Rigorously tested for purity and potency
On December 14, 2023, "Science" magazine announced the top ten scientific breakthroughs of the year
Understand the interactions & safe medication management for your weight loss journey with expert medical guidance.
Chandrasekhar K et al
